Trial intelligence / Profile preview

Wuwei Kushen Enteric-Coated Capsules in Active Ulcerative Colitis

CTR20180728Phase 4Active

Sponsor
Beijing Zhonghui Pharmaceutical
Start
May 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Wuwei Kushen in autoimmune colitis, sponsored by Beijing Zhonghui Pharmaceutical. Started May 2018; status: active.

02

Drugs

Wuwei Kushen
03

Conditions

autoimmune colitis

Beyond the preview

Go deeper on CTR20180728.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20180728.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call